Skip to main content
. 2015 Sep 21;2:8. doi: 10.1186/s40661-015-0015-0

Fig. 2.

Fig. 2

Indications granted FDA regulatory approval for Bevacizumab for solid tumors treatment. Abbreviations: VEGF-A: vascular endothelial growth factor; IND: Investigational New Drug Application; NSCLC: non-small cell lung cancer; BC: breast cancer; RCC: renal carcinoma; CRC: colorectal cancer; OC: ovarian cancer